Login
Donate
  • About
    • Board of Directors
    • Standing Committee
    • Ad Hoc Committee
    • Volunteering
    • Become a Member
  • Meeting
  • Member Resources
  • News & Education
    • News
    • Education Committee
    • Destigmatizing SUD Language
    • Researchers Conducting Human Research
    • Drug and Alcohol Dependence
    • Drug and Alcohol Reports
    • Issues of Newsline
    • CPDD/AMP Animals in Research Policy Fellowship
  • Support CPDD

In the News – Dr. Mark Smith: Establishing Preclinical Models to Investigate the Role of Social Learning on the Acquisition of Cocaine Self-Administration

by Alison Porter | Sep 10, 2026 | Member Spotlight

Epidemiological studies have shown repeatedly that one of the best prognosticators of adolescent or young adult drug use is whether an individual’s peers use drugs. The high concordance rates of drug use within peer groups can be explained by either selection theories...

In the News – Dr. Greg Collins: Preclinical Investigations of Synthetic Cathinones (i.e. “Bath Salts”)

by Alison Porter | Sep 10, 2026 | Member Spotlight

Dr. Greg Collins is using procedures in laboratory animals to understand aspects related to designer psychostimulant abuse. The rise of designer recreational drugs has added further complication to our efforts to reduce drug addiction and abuse. These drugs are...

In the News – Dr. Cassie Gipson-Reichardt: Neuroinflammation as a Novel Mechanism Underlying Nicotine Relapse

by Alison Porter | Sep 10, 2026 | Member Spotlight

Tobacco use is the greatest preventable cause of death, cancer, and illness in the United States. Some smoking cessation interventions are effective, but the majority of individuals who stop smoking relapse within a year. A better understanding of the mechanisms...

In the News – Dr. Wendy Lynch: Discovering Novel Interventions for Cocaine Addiction Using an Animal Model of Relapse

by Alison Porter | Sep 10, 2026 | Member Spotlight

Although cocaine use is a leading cause of overdose deaths in the US, second only to opioids, there are currently no FDA-approved medications for its treatment. Exercise shows promise as a treatment option given its potential to reduce drug craving and vulnerability...

In the News – Dr. Sarah Withey: Concurrent Assessment of the Antinociceptive and Behaviorally Disruptive Effects of Opioid Analgestics in a Preclinical Model

by Alison Porter | Sep 10, 2026 | Member Spotlight

Opioid analgesics remain the primary treatment for moderate to severe pain, but often cause behavioral impairment that constrains their therapeutic utility. Preclinical antinociception assays in animals have been indispensable in the development of analgesic...

In the News – Dr. Michael Nader: Using Animal Models to Evaluate the Relationship Between Social Status and Social Stress

by Alison Porter | Sep 10, 2026 | Member Spotlight

Stress is an important predictor of substance use and misuse. For example, early-life or chronic stress can contribute to the development of disordered patterns of substance use. Similarly, stressful events may precipitate relapse and continued substance use among...
Next Entries »

About Us

Pay Membership Dues

Join 1929 Sustaining Society

Contact Us

Annual Meeting

  • Follow
  • Follow
  • Follow

The College on Problems of Drug Dependence

5034A Thoroughbred Lane, Brentwood, TN 37027

615-432-0099 • info@cpdd.org

© 2024 The College on Problems of Drug Dependence – CPDD. All Rights Reserved.

The College on Problems of Drug Dependence and CPDD are trademarks of the association. 

Privacy Policy             Terms of Use

Powered by Parthenon Management Group

If you continue to use this site, you accept the use of cookies and other tracking policies.OkPrivacy policy